General
Preferred name
RALTEGRAVIR
Synonyms
MK 0518 potassium salt ()
Raltegravir potassium salt ()
MK-0518 ()
RALTEGRAVIR POTASSIUM ()
Raltegravir (MK-0518) ()
Raltegravir (potassium) ()
MK 0518 (potassium) ()
MK-0518 potassium ()
MK0518 POTASSIUM ()
Isentress ()
Raltegravir monopotassium salt ()
Isentress hd ()
Raltegravir (potassium salt) ()
Raltegravir-d4 ()
P&D ID
PD009217
CAS
871038-72-1
518048-05-0
2712343-38-7
Tags
natural product
drug
available
Approved by
PMDA
EMA
FDA
First approval
2007
Drug Status
approved
Drug indication
Human immunodeficiency virus infection
Max Phase
Phase 4
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
MOA
Raltegravir inhibits HIV integrase to prevent the viral genome being incorporated into the human genome. Raltegravir is primarily metabolized by glucuronidation.
DESCRIPTION
Raltegravir (MK-0518) is an HIV integrase inhibitor (integrase strand transfer inhibitor) .
(GtoPdb)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
0
Organisms
4
Compound Sets
23
Axon Medchem Screening Library
CeMM library of unique drugs (CLOUD)
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
Enamine BioReference Compounds
EU-OPENSCREEN Bioactive Compound Library
Guide to Pharmacology
LSP-MoA library (Laboratory of Systems Pharmacology)
NCATS Inxight Approved Drugs
ReFrame library
Selleckchem Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
53
Properties
(calculated by RDKit )
Molecular Weight
444.16
Hydrogen Bond Acceptors
9
Hydrogen Bond Donors
3
Rotatable Bonds
6
Ring Count
3
Aromatic Ring Count
3
cLogP
0.91
TPSA
152.24
Fraction CSP3
0.3
Chiral centers
0.0
Largest ring
6.0
QED
0.51
QED
0.51
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
MOA
viral integrase inhibitor
HIV Protease inhibitor
Integrase inhibitor
HIV integrase inhibitor
Target
Gag-Pol polyprotein
Human immunodeficiency virus type 1 integrase
HIV
Integrase (IN)
Integrase (S217Q PFV)
Integrase (WT PFV)
HIV Integrase
Integrase
Pathway
Microbiology&virology
Proteases/Proteasome
Anti-infection
Metabolic Enzyme/Protease
Indication
human immunodeficiency virus (HIV-1)
VGSC Target
Nav1.5
Source data